Aarey Drugs & Pharmaceuticals P/E Ratio
Current P/E Ratio
64.02
High Valuation
Very High - High growth expectations or significantly overvalued
Aarey Drugs & Pharmaceuticals (AAREYDRUGS) P/E ratio is 64.02 (High), EPS (TTM) ₹1.39, current price ₹81.20 on NSE — Very High - High growth expectations or significantly overvalued. View AAREYDRUGS yearly price range for the annual high/low range and current price position.
Current Valuation Metrics
P/E Ratio
64.02
Current Price
₹81.20
EPS (TTM)
₹1.39
Exchange
NSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
54.84
Sector Median
30.62
Sector Rank
#11 of 198
Sector Percentile
5.6%
AAREYDRUGS P/E Ratio — Valuation Signal & Historical Context
Aarey Drugs & Pharmaceuticals P/E 64.02 — signal: Overvalued. Compare with AAREYDRUGS fair price to assess whether the stock is under or overvalued.
- Stock appears overvalued with PE of 64.02, suggesting caution for new investments
- Trading at premium to sector average PE of 54.84
AAREYDRUGS vs Healthcare Peers — P/E Ratio Comparison
Aarey Drugs & Pharmaceuticals P/E 64.02 vs Healthcare average 54.84, median 30.62 — range 2.86–706.0.
Sector Average
54.84
Sector Median
30.62
Lowest P/E
2.86
Highest P/E
706.0
Companies
198
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 2.98 | ₹52 | Low |
| Colinz Laboratories | COLINZ | 3.6 | ₹10 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.05 | ₹6,404 | Low |
| Sunrest Lifescience | SUNREST | 4.19 | ₹67 | Low |
| Shelter Pharma | SHELTER | 4.99 | ₹46 | Low |
| JFL Life Sciences | JFLLIFE | 5.83 | ₹78 | Low |
| GKB Ophthalmics | GKB | 5.94 | ₹33 | Low |
| Dipna Pharmachem | DPL | 6.52 | ₹18 | Low |
| Royal Sense | ROYAL | 6.73 | ₹48 | Low |